1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE
Compound with spectra: 1 NMR
![1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE](/api/compound/EsydPtiXuWC.png?ph=true&h=300&w=458 "1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE")
| SpectraBase Compound ID | EsydPtiXuWC |
|---|---|
| InChI | InChI=1S/C30H34ClN5O/c1-36(34-29(37)15-7-3-6-12-23-10-4-2-5-11-23)20-18-35(19-21-36)30-25-13-8-9-14-26(25)32-27-17-16-24(31)22-28(27)33-30/h2,4-5,8-11,13-14,16-17,22,32H,3,6-7,12,15,18-21H2,1H3 |
| InChIKey | BCCWRGQLPWGRCV-UHFFFAOYSA-N |
| Mol Weight | 516.1 g/mol |
| Molecular Formula | C30H34ClN5O |
| Exact Mass | 515.245188 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(8-PHENYL)-OCTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-2-(PHENYL)-ACETIMIDE
Clozapine-M (7 OH)
Clozapine-M (6 OH)
Clozapine ME
(12-N-Methyl)-11-(o-methylaniline)-5H-dibenzo[b,e][1,4]diazepines
(12-N-Methyl)-11-(o-bromoaniline)-5H-dibenzo[b,e][1,4]diazepines
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS Acting Agents. II Design, Synthesis, and Receptor Binding of 4′-Arylalkyl Aminimide Analogues of Clozapine as Prospective Novel Antipsychotics | Australian Journal of Chemistry | 2008 |